Strong medicine: creating incentives for pharmaceutical research on neglected diseases
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Format: | Buch |
| Sprache: | English |
| Veröffentlicht: |
Princeton and Oxfordshire
Princeton University Press
[2004]
|
| Schlagworte: | |
| Online-Zugang: | Contributor biographical information Publisher description |
| Beschreibung: | Literaturangaben |
| Beschreibung: | xiv, 153 Seiten Diagramme |
| ISBN: | 0691121133 9780691171166 |
Internformat
MARC
| LEADER | 00000nam a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV019755980 | ||
| 003 | DE-604 | ||
| 005 | 20170306 | ||
| 007 | t | ||
| 008 | 050401s2004 xxu|||| |||| 00||| eng d | ||
| 010 | |a 2004050384 | ||
| 020 | |a 0691121133 |9 0-691-12113-3 | ||
| 020 | |a 9780691171166 |9 978-0-691-17116-6 | ||
| 035 | |a (OCoLC)55596208 | ||
| 035 | |a (DE-599)BVBBV019755980 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 044 | |a xxu |c US | ||
| 049 | |a DE-12 |a DE-703 |a DE-M382 | ||
| 050 | 0 | |a RS122 | |
| 082 | 0 | |a 362.17/82/091724 |2 22 | |
| 084 | |a VS 5350 |0 (DE-625)147687:253 |2 rvk | ||
| 100 | 1 | |a Kremer, Michael |d 1964- |0 (DE-588)128650532 |4 aut | |
| 245 | 1 | 0 | |a Strong medicine |b creating incentives for pharmaceutical research on neglected diseases |c Michael Kremer and Rachel Glennerster |
| 264 | 1 | |a Princeton and Oxfordshire |b Princeton University Press |c [2004] | |
| 264 | 4 | |c © 2004 | |
| 300 | |a xiv, 153 Seiten |b Diagramme | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 500 | |a Literaturangaben | ||
| 650 | 7 | |a Farmaceutische industrie |2 gtt | |
| 650 | 7 | |a Keuzes |2 gtt | |
| 650 | 7 | |a Onderzoek |2 gtt | |
| 650 | 4 | |a Entwicklungsländer | |
| 650 | 4 | |a Pharmacy |x Research |x Economic aspects |z Developing countries | |
| 650 | 4 | |a Drugs |x Research |x Economic aspects |z Developing countries | |
| 650 | 4 | |a Vaccines |x Research |x Economic aspects |z Developing countries | |
| 650 | 0 | 7 | |a Gesundheitsförderung |0 (DE-588)4294611-6 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Forschungsförderung |0 (DE-588)4125049-7 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Forschungsfinanzierung |0 (DE-588)4155044-4 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Arzneimittelforschung |0 (DE-588)4003120-2 |2 gnd |9 rswk-swf |
| 651 | 7 | |a Entwicklungsländer |0 (DE-588)4014954-7 |2 gnd |9 rswk-swf | |
| 689 | 0 | 0 | |a Entwicklungsländer |0 (DE-588)4014954-7 |D g |
| 689 | 0 | 1 | |a Gesundheitsförderung |0 (DE-588)4294611-6 |D s |
| 689 | 0 | 2 | |a Arzneimittelforschung |0 (DE-588)4003120-2 |D s |
| 689 | 0 | 3 | |a Forschungsförderung |0 (DE-588)4125049-7 |D s |
| 689 | 0 | |5 DE-604 | |
| 689 | 1 | 0 | |a Entwicklungsländer |0 (DE-588)4014954-7 |D g |
| 689 | 1 | 1 | |a Gesundheitsförderung |0 (DE-588)4294611-6 |D s |
| 689 | 1 | 2 | |a Arzneimittelforschung |0 (DE-588)4003120-2 |D s |
| 689 | 1 | 3 | |a Forschungsfinanzierung |0 (DE-588)4155044-4 |D s |
| 689 | 1 | |C b |5 DE-604 | |
| 700 | 1 | |a Glennerster, Rachel |d 1965- |0 (DE-588)130514845 |4 aut | |
| 856 | 4 | |u http://www.loc.gov/catdir/bios/prin051/2004050384.html |3 Contributor biographical information | |
| 856 | 4 | |u http://www.loc.gov/catdir/description/prin051/2004050384.html |3 Publisher description | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-013082445 | ||
Datensatz im Suchindex
| _version_ | 1804133229746192384 |
|---|---|
| any_adam_object | |
| author | Kremer, Michael 1964- Glennerster, Rachel 1965- |
| author_GND | (DE-588)128650532 (DE-588)130514845 |
| author_facet | Kremer, Michael 1964- Glennerster, Rachel 1965- |
| author_role | aut aut |
| author_sort | Kremer, Michael 1964- |
| author_variant | m k mk r g rg |
| building | Verbundindex |
| bvnumber | BV019755980 |
| callnumber-first | R - Medicine |
| callnumber-label | RS122 |
| callnumber-raw | RS122 |
| callnumber-search | RS122 |
| callnumber-sort | RS 3122 |
| callnumber-subject | RS - Pharmacy |
| classification_rvk | VS 5350 |
| ctrlnum | (OCoLC)55596208 (DE-599)BVBBV019755980 |
| dewey-full | 362.17/82/091724 |
| dewey-hundreds | 300 - Social sciences |
| dewey-ones | 362 - Social problems and services to groups |
| dewey-raw | 362.17/82/091724 |
| dewey-search | 362.17/82/091724 |
| dewey-sort | 3362.17 282 591724 |
| dewey-tens | 360 - Social problems and services; associations |
| discipline | Chemie / Pharmazie Soziologie |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02629nam a2200649zc 4500</leader><controlfield tag="001">BV019755980</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20170306 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">050401s2004 xxu|||| |||| 00||| eng d</controlfield><datafield tag="010" ind1=" " ind2=" "><subfield code="a">2004050384</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0691121133</subfield><subfield code="9">0-691-12113-3</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780691171166</subfield><subfield code="9">978-0-691-17116-6</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)55596208</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV019755980</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">xxu</subfield><subfield code="c">US</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-12</subfield><subfield code="a">DE-703</subfield><subfield code="a">DE-M382</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RS122</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">362.17/82/091724</subfield><subfield code="2">22</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">VS 5350</subfield><subfield code="0">(DE-625)147687:253</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Kremer, Michael</subfield><subfield code="d">1964-</subfield><subfield code="0">(DE-588)128650532</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Strong medicine</subfield><subfield code="b">creating incentives for pharmaceutical research on neglected diseases</subfield><subfield code="c">Michael Kremer and Rachel Glennerster</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Princeton and Oxfordshire</subfield><subfield code="b">Princeton University Press</subfield><subfield code="c">[2004]</subfield></datafield><datafield tag="264" ind1=" " ind2="4"><subfield code="c">© 2004</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">xiv, 153 Seiten</subfield><subfield code="b">Diagramme</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Literaturangaben</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Farmaceutische industrie</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Keuzes</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Onderzoek</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Entwicklungsländer</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmacy</subfield><subfield code="x">Research</subfield><subfield code="x">Economic aspects</subfield><subfield code="z">Developing countries</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drugs</subfield><subfield code="x">Research</subfield><subfield code="x">Economic aspects</subfield><subfield code="z">Developing countries</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Vaccines</subfield><subfield code="x">Research</subfield><subfield code="x">Economic aspects</subfield><subfield code="z">Developing countries</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Gesundheitsförderung</subfield><subfield code="0">(DE-588)4294611-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Forschungsförderung</subfield><subfield code="0">(DE-588)4125049-7</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Forschungsfinanzierung</subfield><subfield code="0">(DE-588)4155044-4</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittelforschung</subfield><subfield code="0">(DE-588)4003120-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="651" ind1=" " ind2="7"><subfield code="a">Entwicklungsländer</subfield><subfield code="0">(DE-588)4014954-7</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Entwicklungsländer</subfield><subfield code="0">(DE-588)4014954-7</subfield><subfield code="D">g</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Gesundheitsförderung</subfield><subfield code="0">(DE-588)4294611-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Arzneimittelforschung</subfield><subfield code="0">(DE-588)4003120-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="3"><subfield code="a">Forschungsförderung</subfield><subfield code="0">(DE-588)4125049-7</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Entwicklungsländer</subfield><subfield code="0">(DE-588)4014954-7</subfield><subfield code="D">g</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Gesundheitsförderung</subfield><subfield code="0">(DE-588)4294611-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="2"><subfield code="a">Arzneimittelforschung</subfield><subfield code="0">(DE-588)4003120-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="3"><subfield code="a">Forschungsfinanzierung</subfield><subfield code="0">(DE-588)4155044-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="C">b</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Glennerster, Rachel</subfield><subfield code="d">1965-</subfield><subfield code="0">(DE-588)130514845</subfield><subfield code="4">aut</subfield></datafield><datafield tag="856" ind1="4" ind2=" "><subfield code="u">http://www.loc.gov/catdir/bios/prin051/2004050384.html</subfield><subfield code="3">Contributor biographical information</subfield></datafield><datafield tag="856" ind1="4" ind2=" "><subfield code="u">http://www.loc.gov/catdir/description/prin051/2004050384.html</subfield><subfield code="3">Publisher description</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-013082445</subfield></datafield></record></collection> |
| geographic | Entwicklungsländer (DE-588)4014954-7 gnd |
| geographic_facet | Entwicklungsländer |
| id | DE-604.BV019755980 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-09T20:05:24Z |
| institution | BVB |
| isbn | 0691121133 9780691171166 |
| language | English |
| lccn | 2004050384 |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-013082445 |
| oclc_num | 55596208 |
| open_access_boolean | |
| owner | DE-12 DE-703 DE-M382 |
| owner_facet | DE-12 DE-703 DE-M382 |
| physical | xiv, 153 Seiten Diagramme |
| publishDate | 2004 |
| publishDateSearch | 2004 |
| publishDateSort | 2004 |
| publisher | Princeton University Press |
| record_format | marc |
| spelling | Kremer, Michael 1964- (DE-588)128650532 aut Strong medicine creating incentives for pharmaceutical research on neglected diseases Michael Kremer and Rachel Glennerster Princeton and Oxfordshire Princeton University Press [2004] © 2004 xiv, 153 Seiten Diagramme txt rdacontent n rdamedia nc rdacarrier Literaturangaben Farmaceutische industrie gtt Keuzes gtt Onderzoek gtt Entwicklungsländer Pharmacy Research Economic aspects Developing countries Drugs Research Economic aspects Developing countries Vaccines Research Economic aspects Developing countries Gesundheitsförderung (DE-588)4294611-6 gnd rswk-swf Forschungsförderung (DE-588)4125049-7 gnd rswk-swf Forschungsfinanzierung (DE-588)4155044-4 gnd rswk-swf Arzneimittelforschung (DE-588)4003120-2 gnd rswk-swf Entwicklungsländer (DE-588)4014954-7 gnd rswk-swf Entwicklungsländer (DE-588)4014954-7 g Gesundheitsförderung (DE-588)4294611-6 s Arzneimittelforschung (DE-588)4003120-2 s Forschungsförderung (DE-588)4125049-7 s DE-604 Forschungsfinanzierung (DE-588)4155044-4 s b DE-604 Glennerster, Rachel 1965- (DE-588)130514845 aut http://www.loc.gov/catdir/bios/prin051/2004050384.html Contributor biographical information http://www.loc.gov/catdir/description/prin051/2004050384.html Publisher description |
| spellingShingle | Kremer, Michael 1964- Glennerster, Rachel 1965- Strong medicine creating incentives for pharmaceutical research on neglected diseases Farmaceutische industrie gtt Keuzes gtt Onderzoek gtt Entwicklungsländer Pharmacy Research Economic aspects Developing countries Drugs Research Economic aspects Developing countries Vaccines Research Economic aspects Developing countries Gesundheitsförderung (DE-588)4294611-6 gnd Forschungsförderung (DE-588)4125049-7 gnd Forschungsfinanzierung (DE-588)4155044-4 gnd Arzneimittelforschung (DE-588)4003120-2 gnd |
| subject_GND | (DE-588)4294611-6 (DE-588)4125049-7 (DE-588)4155044-4 (DE-588)4003120-2 (DE-588)4014954-7 |
| title | Strong medicine creating incentives for pharmaceutical research on neglected diseases |
| title_auth | Strong medicine creating incentives for pharmaceutical research on neglected diseases |
| title_exact_search | Strong medicine creating incentives for pharmaceutical research on neglected diseases |
| title_full | Strong medicine creating incentives for pharmaceutical research on neglected diseases Michael Kremer and Rachel Glennerster |
| title_fullStr | Strong medicine creating incentives for pharmaceutical research on neglected diseases Michael Kremer and Rachel Glennerster |
| title_full_unstemmed | Strong medicine creating incentives for pharmaceutical research on neglected diseases Michael Kremer and Rachel Glennerster |
| title_short | Strong medicine |
| title_sort | strong medicine creating incentives for pharmaceutical research on neglected diseases |
| title_sub | creating incentives for pharmaceutical research on neglected diseases |
| topic | Farmaceutische industrie gtt Keuzes gtt Onderzoek gtt Entwicklungsländer Pharmacy Research Economic aspects Developing countries Drugs Research Economic aspects Developing countries Vaccines Research Economic aspects Developing countries Gesundheitsförderung (DE-588)4294611-6 gnd Forschungsförderung (DE-588)4125049-7 gnd Forschungsfinanzierung (DE-588)4155044-4 gnd Arzneimittelforschung (DE-588)4003120-2 gnd |
| topic_facet | Farmaceutische industrie Keuzes Onderzoek Entwicklungsländer Pharmacy Research Economic aspects Developing countries Drugs Research Economic aspects Developing countries Vaccines Research Economic aspects Developing countries Gesundheitsförderung Forschungsförderung Forschungsfinanzierung Arzneimittelforschung |
| url | http://www.loc.gov/catdir/bios/prin051/2004050384.html http://www.loc.gov/catdir/description/prin051/2004050384.html |
| work_keys_str_mv | AT kremermichael strongmedicinecreatingincentivesforpharmaceuticalresearchonneglecteddiseases AT glennersterrachel strongmedicinecreatingincentivesforpharmaceuticalresearchonneglecteddiseases |